Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4.99M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
63.9M
-
Shares change
-
+24.7M
-
Total reported value, excl. options
-
$1.49B
-
Value change
-
+$669M
-
Put/Call ratio
-
0.13
-
Number of buys
-
103
-
Number of sells
-
-25
-
Price
-
$23.40
Significant Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q2 2020
144 filings reported holding MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2020.
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.9M shares
.
Largest 10 shareholders include NEA Management Company, LLC (7.96M shares), BlackRock Inc. (7.14M shares), Avoro Capital Advisors LLC (6.5M shares), Consonance Capital Management LP (5.9M shares), Bain Capital Life Sciences Investors, LLC (3.45M shares), WELLINGTON MANAGEMENT GROUP LLP (2.89M shares), VANGUARD GROUP INC (2.86M shares), Sarissa Capital Management LP (2.57M shares), ORBIMED ADVISORS LLC (1.91M shares), and Rock Springs Capital Management LP (1.88M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.